Oneness Biotech Co Ltd - Company Profile
Powered by 
All the data and insights you need on Oneness Biotech Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Oneness Biotech Co Ltd Strategy Report
- Understand Oneness Biotech Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Oneness Biotech Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| HUE057904T2 | Application | METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION | C07K16/00; C07K16/2887; C07K16/4291; C07K2317/14; C07K2317/41; C12N15/85; C12N9/2402; C12N9/2405; C12P21/005; C12Y302/01051; C12Y302/01096; Y02P20/52 | June 28, 2022 |
| WO2022117085A1 | Application | INTERFERING RNAS TARGETING SEVERE ACUTE RESPIRATORY SYNDROME-ASSOCIATED CORONAVIRUS AND USES THEREOF FOR TREATING COVID-19 | June 09, 2022 | |
| PL3119882T3 | Grant | METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION | C07K16/00; C07K16/2887; C07K16/4291; C07K2317/14; C07K2317/41; C12N15/85; C12N9/2402; C12N9/2405; C12P21/005; C12Y302/01051; C12Y302/01096; Y02P20/52 | May 16, 2022 |
| WO2022089595A1 | Application | BIOMARKERS FOR IGE-MEDIATED DISEASES | G01N33/68 | May 05, 2022 |
| ES2904993T3 | Grant | Métodos para la producción de glicoproteínas recombinantes con glicosilación modificada | C07K16/00; C07K16/2887; C07K16/4291; C07K2317/14; C07K2317/41; C12N15/85; C12N9/2402; C12N9/2405; C12P21/005; C12Y302/01051; C12Y302/01096; Y02P20/52 | April 06, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer